Diagnostic imaging is a non-invasive method for identifying and monitoring diseases or injuries by generating the images of internal anatomic structures and organs of the body for diagnosis purpose. Advances in diagnostic imaging technology has redefined how physicians diagnose and treat some of the most life threatening diseases such as cancer and heart disease and they have nearly eliminated the need for exploratory surgery. The use of diagnostic imaging devices is increasing significantly due to increased demand by patients and physicians as they provide precise information of disease condition which will help physicians to treat patients effectively and play an important role in the early diagnosis and prevention of disease. According to American Heart Association (AHA), cardiovascular disease accounts for approximately 836,546 deaths in the United States in 2017 about 92.1 million Americans suffer from different cardiovascular condition. As per WHO (World Health Organization) survey, around 8.8 million people died worldwide from cancer in 2018 and it is estimated that 60% of world’s total new cases with cancer is observed in Africa, Asia, South and Central American regions. The global mortality rate is increasing due to the increase in the prevalence of chronic diseases and can be reduced by early detection of diseases. Therefore, the usage of diagnostic imaging modalities such as CT, MRI, X-ray, Nuclear Imaging, Ultrasound and mammography are increasing.
Technological advancements such as Automated Breast Ultrasound (ABUS), Ultra Low Field MRI (at field strength approximately equal to earth’s magnetic field), Magnetoencephalography (MEG), Digital Breast Tomosynthesis (DBT), and imaging devices with a low dose of ionizing radiations are driving the diagnostic imaging market. Recent technological advancements like hybrid imaging systems (PET/CT, PET/MRI and SPECT/CT) that can provide precise images with better resolution reduced patient radiation dose and provide more physiological data compared to standalone systems. And contrast agent assisted imaging like the use of a Perflutren lipid or protein microsphere along with gases such as perflurocarbon is enhancing the efficiency of echocardiography and also used for the extended indication for imaging liver, kidney and breast are boosting the growth of diagnostic imaging market. Advancements in image resolution in CT and x-ray devices have further increased the use of these devices in diseases diagnosis. For instance, Canon medical system’s Aquilion Precision CT system is world’s first Ultra-High Resolution CT capable of resolving anatomy as small as 150 microns, providing CT image quality with resolution typically seen only in cath labs.
Availability of advanced products and with technological innovations occurring at a rapid pace in the diagnostic imaging market, physicians prefer to employ treatments which have more success rates, lower risk of complications and lesser turnaround time. For instance, Clarius Mobile Health introduced new advanced features for its C3 and L7 wireless ultrasound sound scanner that provides quick scans of the heart, abdomen and lungs. These handheld ultrasound scanners send wireless data to most iOS or android smart devices and give clinicians the availability to perform quick scans anywhere providing an efficient and accurate diagnosis. Thus technological advancements in different modalities are driving the diagnostic imaging devices market.
The refurbished diagnostic imaging devices market is also growing at a good pace due to increased adoption of low-cost refurbished devices due to cost pressures, high demand for refurbished devices from developing countries, increased sales through online marketing and the most significant driver is developing new technology. The technological advancements in diagnostic imaging field is rapid and therefore the intervals between the purchases of advanced systems are shortening, and a greater number of devices with significant use periods still remaining are being returned to the original equipment manufacturer (OEMs) or bought by third parties to sell on. Most commonly refurbished diagnostic imaging devices are X-ray equipment, CT, MRI and ultrasound scanners as they are generally been designed to use for an extended period
Geographically, North American region commanded the largest share in the diagnostic imaging devices global market followed by Europe, Asia-Pacific and Rest of the World. Increasing growth in the aging population with life threatening diseases and a significant increase in diagnostic centers in the U.S. has led the market growth in North America region. Asia-Pacific is the fastest growing region, mainly driven by the increased incidences of chronic illness and improving healthcare infrastructure in the region through investments from private sectors and government agencies.
Major players in the diagnostic imaging devices global market are Carestream Health, Inc. (U.S.), GE Healthcare (U.S.), Siemens Healthcare (Germany), Philips N.V (Netherlands), Hitachi Medical Corporation (Japan), Hologic, Inc. (U.S.), Shimadzu Corporation (Japan), Canon Medical Systems Corporation (Japan), Fujifilm Holdings Corporation (Japan) and Shenzhen Mindray Bio-Medical Electronics (China).
Please visit our website for further information: https://www.iq4i.com/reports-category/medicaldevices/r/179
Please write to us: email@example.com